Loading clinical trials...

Effect of Enhanced External Counterpulsation | Clinical Trials | Clareo Health

COMPLETEDNA

Effect of Enhanced External Counterpulsation

Effect of Enhanced External Counterpulsation on the Rehabilitation of Patients With Acute Myocardial Infarction After Drug-Coated Balloon-Based Percutaneous Coronary Intervention

NCT06877390•Chongming Hospital Affiliated to Shanghai University of Health & Medicine Sciences

View on ClinicalTrials.gov

Summary

This study evaluated the efficacy and safety of enhanced extracorporeal counterpulsation for cardiac rehabilitation in patients after DCB for acute myocardial infarction.

Eligibility

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•patients with AMI diagnosed based on the universal definition of myocardial infarction criteria
•a single vessel infarcted, and Syntax score ≤22
•patients treated using DCB
•patients without EECP contraindications
•patients aged 18-75 years
•patients who had signed informed consent and were able to cooperate in completing the study

Exclusion Criteria

•patients with lower limb deep venous thrombosis and active thrombophlebitis
•patients with moderate to severe valvular heart disease, especially those with aortic insufficiency and/or stenosis
•patients with moderate to severe pulmonary arterial hypertension (mean pulmonary arterial pressure \>50 mmHg)
•patients with aortic, cerebral or dissecting aneurysms
•patients with uncontrolled hypertension (\>180/110 mmHg)
•patients with decompensated heart failure (cardiac function of grade IV)
•patients with arrhythmia that might interfere with the electrocardiographic gating function of the EECP device
•patients with haemorrhagic diseases or obvious bleeding tendencies
•patients with infected lesions in their limbs that may affect EECP
•pregnant women
+1 more criteria

Locations (1)

P-ECP/TI EECP device

Shanghai, China

Key Dates

Start Date

November 1, 2023

Primary Completion Date

April 30, 2024

Completion Date

April 30, 2024

Last Updated

March 14, 2025

Enrollment

ACTUAL participants

Conditions

Enhanced External Counterpulsation (EECP)Acute Myocardial Infarction (AMI)Drug-coated BalloonCardiac Rehabilitation

Interventions

conventional drug and exercise rehabilitation

OTHER

EECP-based rehabilitation regimen

DEVICE

Fast Discharge After Acute Myocardial Infarction Discharge MI

NCT06744322

Acute Myocardial Infarction (AMI)

View study

RECRUITINGPHASE3

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

NCT06118281

Cardiovascular RiskAcute Myocardial Infarction (AMI)

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 14, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effect of Enhanced External Counterpulsation

Inclusion Criteria

Exclusion Criteria

Fast Discharge After Acute Myocardial Infarction Discharge MI

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Risk Factors for Microvascular Obstruction Post-Emergency PCI in AMI Patients

Myocardial Infarction and Periodontitis: Periodontal Health Intervention.

Identification and Functional Study of Novel Biomarkers for Cardiovascular Diseases

Acute MI Staging Diagnosis by High-sensitivity Cardiac Troponin-I